Ovine Kidney Tissue (Ovis aries)

Ovine kidney tissue (Ovis aries) is a glandular supplement derived from sheep kidneys that contains angiotensin converting enzyme (ACE), a zinc metalloprotease central to blood pressure regulation via the renin-angiotensin system. Current research on sheep kidney tissue is limited primarily to contaminant studies, with no clinical trials establishing therapeutic benefits in humans.

Origin & History

Ovine kidney tissue derives from the kidneys of sheep (Ovis aries), a domesticated ruminant mammal commonly raised for meat, wool, and other products. Available research describes tissue preparation methods involving thawing, drying, powdering, and homogenization of raw kidney tissue for analytical purposes, though no specific extraction methods for biomedical supplement use are documented in the literature.

Historical & Cultural Context

No historical or traditional medicinal uses of ovine kidney tissue in any systems (including Ayurveda or TCM) are documented in available sources. Sheep (Ovis aries) are primarily noted for agricultural uses like meat and wool production.

Health Benefits

• No documented health benefits - available research focuses solely on contaminant analysis in sheep kidney tissue
• Potential toxicity risk - studies show uranium accumulation in kidneys from mining-exposed sheep (149-176 ng/g vs. 34 ng/g in controls)
• Contains angiotensin converting enzyme (ACE) activity (PMID: 8136703) - though no therapeutic applications studied
• H19 gene expression documented in kidney tissue (PMID: 12490325) - but no supplementation benefits established
• No clinical evidence exists for any therapeutic use in humans

How It Works

Ovine kidney tissue contains angiotensin converting enzyme (ACE), a zinc-dependent metalloprotease (EC 3.4.15.1) that cleaves angiotensin I into the vasoconstrictor angiotensin II and degrades the vasodilator bradykinin, thereby influencing vascular tone. Whether orally ingested ACE from animal tissue survives gastric proteolysis and exerts systemic enzymatic activity in humans remains unestablished. Additionally, kidney tissue contains mitochondrial enzymes and cofactors such as coenzyme Q10 and cytochrome c oxidase subunits, though their bioavailability from this matrix is not documented.

Scientific Research

No human clinical trials, RCTs, or meta-analyses on ovine kidney tissue as a supplement were identified. Available studies are limited to animal tissue analysis for environmental contaminants, particularly uranium accumulation in sheep grazing near mining sites, and descriptive studies on enzyme distribution (PMID: 8136703) and gene expression (PMID: 12490325).

Clinical Summary

No controlled human clinical trials have investigated ovine kidney tissue as a dietary supplement for any health outcome. Available published research consists exclusively of environmental contaminant studies, including analyses showing uranium concentrations of 149–176 ng/g dry weight in kidneys of sheep grazing near uranium mining sites, compared to approximately 34 ng/g in control animals. These findings indicate that sheep kidney tissue can bioaccumulate heavy metals, raising concerns about the safety of unsourced glandular products rather than demonstrating therapeutic utility. The evidence base is therefore insufficient to support any health claim for this ingredient.

Nutritional Profile

Ovine kidney tissue is a nutrient-dense organ meat with a well-characterized macronutrient and micronutrient composition based on general ruminant kidney tissue data. Macronutrients (per 100g raw tissue): Protein: ~16-17g, comprising complete amino acids including lysine (~1.4g), leucine (~1.3g), and arginine (~1.0g); Fat: ~3-4g, with a mixed fatty acid profile including oleic acid, palmitic acid, and small amounts of arachidonic acid; Carbohydrates: <1g; Water: ~78-80g; Calories: ~90-100 kcal. Micronutrients (per 100g): Vitamin B12: ~27-30µg (450-500% RDI - exceptionally high, highest bioavailability form as methylcobalamin); Riboflavin (B2): ~2.0-2.5mg; Niacin (B3): ~7-9mg; Folate: ~80-100µg; Iron (heme form): ~4-5mg (high bioavailability ~25-35%); Zinc: ~2-3mg; Selenium: ~100-150µg (bioavailability ~80%); Copper: ~0.3-0.4mg; Phosphorus: ~230-250mg. Bioactive compounds: Angiotensin converting enzyme (ACE) activity confirmed (PMID: 8136703), though ACE proteins are largely denatured during processing; Coenzyme Q10: ~4-5mg/100g; Carnitine: ~50-60mg/100g; Taurine: ~150-200mg/100g. Critical contamination concern: Uranium accumulates preferentially in renal cortex tissue; mining-exposed sheep show 149-176 ng/g uranium vs. 34 ng/g in controls, representing a 4-5x elevation. H19 gene expression (imprinted growth-regulatory gene) is documented in ovine kidney tissue, relevant to cellular proliferation signaling but of unknown dietary consequence. Bioavailability is generally high for organ-derived nutrients due to the food matrix structure.

Preparation & Dosage

No clinically studied dosage ranges, forms, or standardization protocols exist for ovine kidney tissue as a supplement. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

No synergistic ingredients identified due to lack of therapeutic research

Safety & Interactions

Ovine kidney tissue carries a documented risk of heavy metal contamination, particularly uranium accumulation, which at elevated concentrations is nephrotoxic and can damage proximal tubule cells in the human kidney. Individuals with existing renal impairment, immunocompromise, or those who are pregnant or breastfeeding should avoid this ingredient due to the absence of safety data and potential for concentrated environmental contaminants. Because the tissue contains ACE, theoretical interactions with ACE inhibitor medications (e.g., lisinopril, enalapril) and angiotensin II receptor blockers cannot be excluded, though no interaction studies exist. Prion disease risk associated with ruminant-derived tissue products, while not specifically documented for ovine kidney supplements, represents an additional theoretical safety concern per regulatory guidance on bovine and ovine materials.